Management of Parapneumonic Effusions

References

1. Sahn SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis. 1993;148:813-817.

2. Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax. 2011;66:663-668.

3. Rahman NM, Maskell NA, Davies CW, Hedley EL, Nunn AJ, Gleeson FV, Davies RJ. The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010;137:536-543.

4. Davies HE, Davies RJ, Davies CW. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii41-ii53.

5. Hippocrates. The GenuineWorks ofHippocrates. Whitefish, MT: Kessinger;2007.

6. Cameron R, DaviesHR. Intrapleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema. Cochrane Database

Syst Rev. 2008;2:CD002312.

7. Christie NA. Management of pleural space: effusions and empyema. Surg Clin North Am. 2010;90:919-934.

8. Rahman NM, Chapman SJ, Davies RJ. The approach to the patient with a parapneumonic effusion. Clin Chest Med. 2006;27:253-266.

9. Davies HE, Lee YCG. Pleural effusion, empyema and pneumothorax. In:Albert SS, Jett JR, eds. Clinical Respiratory Medicine. 3rd ed. Philadelphia, PA: Mosby Elsevier 2008:853-868.

10. ShieldsTW. Anatomy of the pleura. In: ShieldsTW, LoCicero, J, Reed, CE, Feins, RH, eds. General Thoracic Surgery. Philadelphia, PA: Lippincott Williams & Wilkins 2005:729-733.

11. Light RW. Physiology of pleural fluid production. In: Shields H, LoCicero, J, Reed, CE, Feins RH, eds. General Thoracic Surgery. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins 2005:763-769.

12. Kocijancic I, Kocijancic K, Cufer T. Imaging of pleural fluid in healthy individuals. Clin Radiol. 2004;59:826-829.

13. Delvaeye M, Conway EM. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114:2367-2374.

14. Finigan JH. The coagulation system and pulmonary endothelial function in acute lung injury. Microvasc Res. 2009;77:35-38.

15. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann, C, Brinkmann V, Lorenz M, Bidzhekov K, Khandagale AB, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med. 2010;16:887-896.

16. Koegelenberg CFN, Diacon AH, Bolliger CT. Parapneumonic pleural effusion and empyema. Respiration. 2008;75:241-250.

17. Cremonesini D, Thomson AH. How should we manage empyema: antibiotics alone, fibrinolytics, or primary video-assisted Thoracoscopic surgery (VATS)? 2007;28:322-332.

18. Gates RL, Caniano DA, Hayes JR, Arca MJ. Does VATS provide optimal treatment of empyema in children? A systematic review. J Pediatr Surg. 2004;39:381-386.

19. Kurian J, Levin TL, Han BK, Taragin BH, Weinstein S. Comparison of ultrasound and CT in the evaluation of pneumonia complicated by parapneumonic effusion in children. AJR Am J Roentgenol 2009;193:1648-1654.

20. Strachan RE, Jaffe A. Recommendations for managing pediatric empyema thoracis. Med J Austr 2011;195:95.

21. Brixey AG, Luo Y, Skouras V, Awdankiewicz A, Light RW. The efficacy of chest radiographs in detecting parapneumonic effusions. Respirology 2011;16:1000-1004

22. Eibenberger KL, Dock WI, Ammann ME, Dorffner R, Hormann MF, Grabenwoger F. Quantification of pleural effusions: sonography versus radiography. Radiology 1994;191:681-684.

23. Heffner JE, Klein JS, Hampson C. Diagnostic utility and clinical application of imaging for pleural space infections. Chest. 2010;137:467-479.

24. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J Clin Ultrasound. 2003;31:69-74.

25. Vignon P, Chastagner C, Berkane V, Chardac E, Francois B, Normand S, Bonnivard M, Clavel M, Pichon N, Preux PM, et al. Quantitative assessment of pleural effusion in critically ill patients by means of ultrasonography. Crit Care Med. 2005;33:1757-1763.

26. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med. 1980;69:507-512.

27. Kocijancic I, Tercelj M, Vidmar K, Jereb M. The value of inspiratoryexpiratory lateral decubitus views in the diagnosis of small pleural effusions. Clin Radiol. 1999;54:595-597.

28. Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest. 1989;95:945-947.

29. Light RW. Clinical practice. Pleural effusion. N Engl J Med. 2002;346: 1971-1977.

30. ColiceGL,Curtis A,Deslauriers J,Heffner J,LightR,Littenberg B,SahnS, Weinstein RA, Yusen RD. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 2000;118:1158-1171.

31. Heffner JE, Brown LK, Barbieri C, DeLeo JM. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis. Am J Respir Crit Care Med. 1995;151:1700-1708.

32. Light RW, MacGregor MI, Ball WC Jr, Luchsinger PC. Diagnostic significance of pleural fluid pH and PCO2. Chest. 1973;64:591-596.

33. Porcel JM. Pleural fluid tests to identify complicated parapneumonic effusions. Curr Opin Pulmonol Med. 2010;16:357-361.

34. Potts DE, Levin DC, Sahn SA. Pleural fluid pH in parapneumonic effusions. Chest. 1976;70:328-331.

35. Fysh ET, SmithNA, Lee YC. Optimal chest drain size: the rise of the smallbore pleural catheter. Semin Respir Crit Care Med. 2010;31:760-768.

36. Light RW. Pleural controversy: optimal chest tube size for drainage. Respirology. 2011;16:244-248.

37. American College of Surgeons Committee on Trauma. Advanced Trauma Life Support for Doctors. 8th ed. Chicago, IL: American College of Surgeons; 2008:108.

38. Chen KY, Hsueh PR, Liaw YS, Yang PC, Luh KT. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest. 2000;117:1685-1689.

39. Falguera M, Carratala J, Bielsa S, Garcia-Vidal C, Ruiz-Gonzalez A, Chica I, Gudiol F, Porcel JM. Predictive factors, microbiology and outcome of patients with parapneumonic effusion. Eur Respir J. 2011;38:1173-1179.

40. Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med. 2006;174:817-823.

41. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, et al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med. 2005;352:865-874.

42. Meyer CN, Rosenlund S, Nielsen J, Friis-Moller A. Bacteriological etiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis. 2011;43:165-169.

43. Porta G, Rodriguez-Carballeira M, Gomez L, Salavert M, Freixas N, Xercavins M, Garau J. Thoracic infection caused by Streptococcus milleri. Eur Respir J. 1998;12:357-362.

44. Ripley RT, Cothren CC, Moore EE, Long J, Johnson JL, Haenel JB. Streptococcus milleri infections of the pleural space: operative management predominates. Am J Surg. 2006;192:817-821.

45. Vaudaux P, Waldvogel FA. Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis. 1980;142:586-593.

46. Sahn SA. Diagnosis and management of parapneumonic effusions and empyema. Clin Infect Dis. 2007;45:1480-1486.

47. Tillett WS, Sherry S. The effect in patients of streptococcal fibrinolysin and streptococcal desoxyribonuclease on fibrinous, purulen, and sanguinous pleural exudations. J Clin Invest. 1949;28:173-190.

48. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community-acquired pleural infection. Thorax. 1997;52:416-421.

49. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: a prospective, double-blind study. Am J Respir Crit Care Med. 1997;155:291-295.

50. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med. 1999;159:37-42.

51. Tuncozgue B, Ustunsoy H, Sirikoz C. Intrapleural urokinase in the management of parapneumonic empyema: a randomized controlled trial. Int J Clin Pract. 2001;55:658-660.

52. Heffner JE. Multicenter trials of treatment for empyema ¾ after all these years. N Engl J Med. 2005;352:926-928.

53. Gervais DA, Levis DA, Hahn PF, Uppot RN, Arellano RS, Mueller PR. Adjunctive intrapleural tissue plasminogen activator administered via chest tubes placed with imaging guidance: effectiveness and risk for hemorrhage. Radiology. 2008;246:956-963.

54. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000;117:1728-1733.

55. Sherry S, tillett WS, Christensen LR. Presence and significance of desoxyribose nucleoprotein in the purulent pleural exudates of patients. Proc Soc Exp Biol Med. 1948;68:179-184.

56. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365:518-526.

57. Mergo PJ, Helmberger T, Didovic J, Cernigliaro J, Ros PR, Staab EV. New formula for quantification of pleural effusions from computed tomography. J Thorac Imaging. 1999;14:122-125.

58. Lee SF, Lawrence D, Booth H, Morris-Jones S, Macrae B, Zumla A. Thoracic empyema: current opinions in medical and surgical management. Curr Opin Pulm Med. 2010;16:194-200.

59. Zahid I, Nagendran M, Routledge T, Scarci M. Comparison of videoassisted thoracoscopic surgery and open surgery in the management of primary empyema. Curr Opin Pulmonol Med. 2011;17:255-259.

60. Katlic MR, Facktor MA. Video-assisted thoracic surgery utilizing local anesthesia and sedation: 384 consecutive cases. Ann Thorac Surg. 2010;90:240-245.

61. Yim A, Shioe, ADL. Video-assisted thoracic surgery as a diagnostic tool. In: Shields TW, Locicero J, Reed CE, Feins RH, eds. General Thoracic Surgery. Philadelphia, PA: Lippincott; 2005:313-323.

62. Deslauriers J, Jacques LF, Gregoire J. Role of Eloesser flap and thoracoplasty in the third millennium. Chest Surg Clin North Am. 2002;12:605-623.

63. Haghshenasskashani A, Rahnavardi M, Yan TD, McCaughan BC. Intrathoracic application of a vacuum-assisted closure device in managing pleural space infection after lung resection: is it an option? Interact Cardiovasc Thorac Surg. 2011;13:168-174.

64. Palman M, Van Breugel HN, Gesgkes GG, Van Belle A, Swennen JM, Drijkoningen AH, Van der Hulst RR, Maessen JG. Open window thoracostomy treatment of empyema is accelerated by vacuum-assisted closue. Ann Thorac Surg. 2009;88:1131-1136.

65. Sziklavari Z, Grosser C, Neu R, Schemm R, Kortner A, Szoke T, Hofmann H-S. Complex pleural empyema can be safely treated with vacuumassisted closure. Cardiothorac Surg. 2011;6:130-138.

66. Schreiner W, Fuchs P, Autschbach R, Pallua N, Sirbu H. Modified technique for thoracomyoplasty after posterolateral thoracotomy. Thorac Cardiovasc Surg. 2010;58:98-101.

67. Walsh MD, Bruno AD, Onaitis MW, Erdmann D, Wolfe WG, Toloza EM, Levin LS. The role of intrathoracic free flaps for chronic empyema. Ann Thorac Surg. 2011;91:865-868.